Knowles Corp Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $614.1M+10.9% YoYTTM through 31 Mar 2026
Net Income $55.9MTTM through 31 Mar 2026
Free Cash Flow $96MTTM through 31 Mar 2026
Margins
| Current | |
|---|---|
| Gross Margin | 43.2% |
| EBITDA Margin | 19.3% |
| Operating Margin | 11.9% |
| Net Margin | 9.1% |
Returns
8.1%ROE
4.2%ROA
6.4%ROIC
Balance Sheet Health
Debt / Equity0.05x
Current Ratio2.75x
Net Debt$79.8M
Cash & Equivalents$41M
Quality Metrics
Altman Z-Score7.24
Piotroski F-Score8 / 9
FCF Margin15.6%
Rule of 4024.2
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2025: $593.2M
Diluted EPS$0.63TTMFY2025: $0.50
Dividend
No dividend
Capital Allocation
R&D Spend$42.2M
Capex Intensity6.3%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Precision Devices | $328.9M | +9.6% | View detailsExpected to sustain strong organic growth of 6% to 8% annually, supported by capacity expansion in the specialty film product line and new design wins. |
| MedTech & Specialty Audio | $264.3M | +4.3% | View detailsTargeting 2% to 4% annual organic growth, leveraging core strengths in hearing health and premium specialty audio applications. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.